163 related articles for article (PubMed ID: 10898512)
1. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.
Nakanishi T; Hayashi A; Kunisawa J; Tsutsumi Y; Tanaka K; Yashiro-Ohtani Y; Nakanishi M; Fujiwara H; Hamaoka T; Mayumi T
Eur J Immunol; 2000 Jun; 30(6):1740-7. PubMed ID: 10898512
[TBL] [Abstract][Full Text] [Related]
2. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine.
Yoshikawa T; Imazu S; Gao JQ; Hayashi K; Tsuda Y; Shimokawa M; Sugita T; Niwa T; Oda A; Akashi M; Tsutsumi Y; Mayumi T; Nakagawa S
Biochem Biophys Res Commun; 2004 Dec; 325(2):500-5. PubMed ID: 15530420
[TBL] [Abstract][Full Text] [Related]
4. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.
Chen W; Carbone FR; McCluskey J
J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698
[TBL] [Abstract][Full Text] [Related]
5. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
[TBL] [Abstract][Full Text] [Related]
7. Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs.
Bungener L; Huckriede A; Wilschut J; Daemen T
Biosci Rep; 2002 Apr; 22(2):323-38. PubMed ID: 12428908
[TBL] [Abstract][Full Text] [Related]
8. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
Li Y; Ke Y; Gottlieb PD; Kapp JA
J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
[TBL] [Abstract][Full Text] [Related]
9. Intracellular processing of hapten-modified protein for MHC class I presentation: cytoplasmic delivery by pH-sensitive liposomes.
Martin S; Niedermann G; Leipner C; Eichmann K; Weltzien HU
Immunol Lett; 1993 Aug; 37(2-3):97-102. PubMed ID: 8258464
[TBL] [Abstract][Full Text] [Related]
10. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy.
Suzuki R; Oda Y; Utoguchi N; Namai E; Taira Y; Okada N; Kadowaki N; Kodama T; Tachibana K; Maruyama K
J Control Release; 2009 Feb; 133(3):198-205. PubMed ID: 19000727
[TBL] [Abstract][Full Text] [Related]
11. Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses.
Collins DS; Findlay K; Harding CV
J Immunol; 1992 Jun; 148(11):3336-41. PubMed ID: 1588035
[TBL] [Abstract][Full Text] [Related]
12. The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation.
Oh YK; Harding CV; Swanson JA
Vaccine; 1997 Apr; 15(5):511-8. PubMed ID: 9160518
[TBL] [Abstract][Full Text] [Related]
13. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation.
Harding CV; Collins DS; Kanagawa O; Unanue ER
J Immunol; 1991 Nov; 147(9):2860-3. PubMed ID: 1918996
[TBL] [Abstract][Full Text] [Related]
14. Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines.
Nair S; Zhou X; Huang L; Rouse BT
J Immunol Methods; 1992 Aug; 152(2):237-43. PubMed ID: 1386866
[TBL] [Abstract][Full Text] [Related]
15. Sendai virus fusion protein mediates simultaneous induction of MHC class I/II-dependent mucosal and systemic immune responses via the nasopharyngeal-associated lymphoreticular tissue immune system.
Kunisawa J; Nakanishi T; Takahashi I; Okudaira A; Tsutsumi Y; Katayama K; Nakagawa S; Kiyono H; Mayumi T
J Immunol; 2001 Aug; 167(3):1406-12. PubMed ID: 11466359
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
[TBL] [Abstract][Full Text] [Related]
17. Virosome-mediated delivery of protein antigens to dendritic cells.
Bungener L; Serre K; Bijl L; Leserman L; Wilschut J; Daemen T; Machy P
Vaccine; 2002 May; 20(17-18):2287-95. PubMed ID: 12009284
[TBL] [Abstract][Full Text] [Related]
18. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
20. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
Mandal M; Lee KD
Biochim Biophys Acta; 2002 Jun; 1563(1-2):7-17. PubMed ID: 12007619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]